Differential effects of human blood monocytes on the growth of human tumour cell lines in vitro Heather J. ParryRobert C. Rees Original articles Pages: 355 - 360
Comparative efficiencies of bispecific F(ab′γ)2 and chimeric mouse/human IgG antibodies in recruiting cellular effectors for cytotoxicity via Fcγ receptors John GreenmanNancy HoggMartin Glennie Original articles Pages: 361 - 369
Enhancement of epidermal growth factor receptor expression on glioma cells by recombinant tumor necrosis factor α Koji AdachiPaul BelserDorothee Herlyn Original articles Pages: 370 - 376
Complement-dependent lysis of tumor cells by a baboon IgM antibody to a tumor-associated antigen Kelly K. HuntMasahiko ShibataDonald L. Morton Original articles Pages: 377 - 382
Postsurgical adjuvant chemoimmunotherapy with recombinant interleukin-2 and 1,3-bis-(2-chloroethyl)-1-nitrosurea on spontaneous metastases of a non-immunogenic murine tumour Giulia AcerbisLoredana ClerisFranca Formelli Original articles Pages: 383 - 388
Effect ofNocardia rubra cell-wall skeleton on cancer prevention in humans Michio YamakidoShinichi IshiokaYukio Nishimoto Original articles Pages: 389 - 392
Role of interferon γ and tumour necrosis factor α in monocyte-mediated cytostasis and cytotoxicity against a human histiocytic lymphoma cell line Arjan A. van de LoosdrechtGert J. OssenkoppeleMart M. A. C. Langenhuijsen Original articles Pages: 393 - 398
Selection of tumor cell variants for resistance to tumor necrosis factor also induces a form of pleiotropic drug resistance Susan C. WrightAlbert W. TamPoornima Kumar Original articles Pages: 399 - 406
Anti-(human LFA-1) monoclonal antibodies bind P815 murine tumour cells Marie-José PalissonAnne AltemeyerPierre Bischoff Original articles Pages: 407 - 413
Ability of recombinant interferon γ in vitro to restore the defective polymorphonuclear-cell-but not lymphocyte-mediated cytotoxic activities in patients with myelodysplastic syndromes Giuliana De SanctisVincenzo BottariLuigi Fontana Original articles Pages: 414 - 418
Cytotoxic T cell lines recognize autologous and allogeneic melanomas with shared or cross-reactive HLA-A Yoshihiko HayashiDave S. B. HoonDonald L. Morton Short communication Pages: 419 - 423
Low-dose recombinant interleukin-2 and low-dose cyclophosphamide in metastatic breast cancer Darcy V. SpicerAnn KelleyMalcolm S. Mitchell Short communication Pages: 424 - 426